Clinical trial
Evaluation of a New Diagnostic Approach to Familial Amyloid Neuropathy by Mutation of the TTR Gene in a Population of Idiopathic Chronic Neuropathies
NCT03720275 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of a New Diagnostic Approach to Familial Amyloid Neuropathy by Mutation of the TTR Gene in a Population of Idiopathic Chronic Neuropathies
- Lead sponsor
- University Hospital, Bordeaux
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 27, 2018
- Completion date
- December 23, 2021
- Enrollment
- 130 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.